ReachMD

Episodes 1-15 of 15

• • 

    

    Cassandra B. Donnelly, DO

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  3

  

  RestartResume

  Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis

  Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis

  0.25 credits

• • 

    

    Cassandra B. Donnelly, DO

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  6

  

  RestartResume

  Act Fast: Understanding Flu Prevention and Treatment in At-Risk Populations

  Act Fast: Understanding Flu Prevention and Treatment in At-Risk Populations

  0.25 credits

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Andrea Steck, MD

    Peer

  • 

    

    Anette Gabriele Ziegler, MD

    Peer

  1

  

  RestartResume

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  0.50 credits

• • 

    

    Christie M. Ballantyne, MD

    Peer

  • 

    

    John J. Russell, MD

    Peer

  5

  

  RestartResume

  Optimizing Outcomes in Familial Hypercholesterolemia: Diagnosis, Treatment, and Management

  Optimizing Outcomes in Familial Hypercholesterolemia: Diagnosis, Treatment, and Management

  0.50 credits

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Stephen Gitelman, MD

    Peer

  2

  

  RestartResume

  Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -- Anti-CD3 Monoclonal Antibodies to Prevent/Delay Onset of Type 1 Diabetes

  Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -- Anti-CD3 Monoclonal Antibodies to Prevent/Delay Onset of Type 1 Diabetes

  0.50 credits

• • 

    

    Hector O. Chapa, MD

    Peer

  • 

    

    Colin Quinn, MD

    Peer

  • 

    

    Matthew Wicklund, MD

    Peer

  2

  

  RestartResume

  Updates in Muscular Dystrophy: A Focus on LGMD

  Updates in Muscular Dystrophy: A Focus on LGMD

  0.25 credits

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Chantal Mathieu, MD, PhD

    Peer

  2

  

  RestartResume

  Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

  Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

  0.50 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Crystal Proud, MD

    Peer

  • 

    

    Edward Clinton Smith, MD

    Peer

  5

  

  RestartResume

  Updates in Muscular Dystrophy: A Focus on DMD 

  Updates in Muscular Dystrophy: A Focus on DMD 

  0.25 credits

• • 

    

    Octavia Pickett-Blakely, MD, MHS

    Peer

  2

  

  RestartResume

  Restoring Matt’s Independence: Tailoring Treatment Strategies to Reduce the Burden of Parenteral Support for Patients with SBS

  Restoring Matt’s Independence: Tailoring Treatment Strategies to Reduce the Burden of Parenteral Support for Patients with SBS

  0.25 credits

• • 

    

    Shannon L. Meeks, MD

    Peer

  • 

    

    Jonathan C. Roberts, MD

    Peer

  4

  

  RestartResume

  Practical Guidance for Surveillance and Reporting in Hemophilia A

  Practical Guidance for Surveillance and Reporting in Hemophilia A

  0.25 credits

• • 

    

    Edward J. Mayeaux, Jr., MD, DABFP, FAAFP

    Peer

  • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  5

  

  RestartResume

  Overcoming Barriers to Young Adult Vaccination: A Call to Action for Frontline Providers

  Overcoming Barriers to Young Adult Vaccination: A Call to Action for Frontline Providers

  0.25 credits

• • 

    

    Andrew Alexis, MD, MPH

    Peer

  • 

    

    Linda Stein Gold, MD

    Peer

  2

  

  RestartResume

  Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

  Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

  0.25 credits

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  9

  

  RestartResume

  Combining Biologics in a Young Patient with Atopic Dermatitis

  Combining Biologics in a Young Patient with Atopic Dermatitis

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  11

  

  RestartResume

  Options for an Infant with Atopic Dermatitis

  Options for an Infant with Atopic Dermatitis

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Joshua D. Lee MD, MSc

    Peer

  39

  

  RestartResume

  Opioid Use Disorder: Expanding Access to Treatment

  Opioid Use Disorder: Expanding Access to Treatment

  0.25 credits